» Articles » PMID: 9286274

Elevated MRNA Expression of Brain-derived Neurotrophic Factor in Retinal Ganglion Cell Layer After Optic Nerve Injury

Overview
Specialty Ophthalmology
Date 1997 Aug 1
PMID 9286274
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Recent studies show that exogenous brain-derived neurotrophic factor (BDNF) can promote retinal ganglion cell survival in vivo and in vitro. BDNF is expressed by a subpopulation of cells in the ganglion cell layer (GCL). To investigate whether endogenous BDNF may play a role in neuronal protection after ganglion cell trauma, BDNF expression in the retina was examined after optic nerve (ON) injury.

Methods: The optic nerve in Sprague-Dawley rats was crushed intraorbitally posterior to the optic disc. For controls, the optic nerve on the opposite side in each animal was similarly exposed but was not crushed. After intervals of 6 hours to 6 weeks, eye tissues were processed for in situ hybridization, Northern blot, and RNase protection assay using radiolabeled rat riboprobes.

Results: After ON injury, BDNF expression was significantly elevated in cells restricted to the GCL, and more cells demonstrated expression of BDNF than were observed in the controls. Elevated BDNF expression was first observed at 24 hours, peaked at 48 hours, and declined to the basal level 2 weeks after ON injury. Quantitative analysis showed a fivefold to sixfold increase in the number of BDNF-positive cells and a 54% increase in BDNF signal intensity in individual cells in the GCL 48 hours after ON injury. In control retinas without ON injury, BDNF expression was localized to some cells in the GCL, as was observed in normal eyes without surgery. Northern blot and RNase protection assay demonstrated a 38% elevation in BDNF expression above control levels 48 hours after ON injury.

Conclusions: These results indicate that cells in the GCL can upregulate gene expression of BDNF in response to ganglion cell axonal injury and suggest that endogenous BDNF may contribute to a natural neuroprotective process after ON injury.

Citing Articles

The role of neurotrophic factors in retinal ganglion cell resiliency.

Abraham A, Telias M Front Cell Neurosci. 2025; 19:1536452.

PMID: 39944766 PMC: 11814206. DOI: 10.3389/fncel.2025.1536452.


Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art.

Lambuk L, Lazaldin M, Ahmad S, Iezhitsa I, Agarwal R, Uskokovic V Front Pharmacol. 2022; 13:875662.

PMID: 35668928 PMC: 9163364. DOI: 10.3389/fphar.2022.875662.


RSK1 promotes mammalian axon regeneration by inducing the synthesis of regeneration-related proteins.

Mao S, Chen Y, Feng W, Zhou S, Jiang C, Zhang J PLoS Biol. 2022; 20(6):e3001653.

PMID: 35648763 PMC: 9159620. DOI: 10.1371/journal.pbio.3001653.


Traumatic optic neuropathy: a review of current studies.

Chen B, Zhang H, Zhai Q, Li H, Wang C, Wang Y Neurosurg Rev. 2022; 45(3):1895-1913.

PMID: 35034261 DOI: 10.1007/s10143-021-01717-9.


A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma.

Dal Monte M, Cammalleri M, Amato R, Pezzino S, Corsaro R, Bagnoli P Int J Mol Sci. 2020; 21(23).

PMID: 33291737 PMC: 7730513. DOI: 10.3390/ijms21239267.